Surveying US Correctional Facilities’ Pandemic Policies on Medication for Opioid Use Disorder
Recently updated data explore key features of COVID-19 mitigation laws regulating MOUD treatment at state correctional facilities.
Medication for Opioid Use Disorder
-
Read more: Surveying US Correctional Facilities’ Pandemic Policies on Medication for Opioid Use Disorder -
Read more: Prior Authorization Insurance Requirements: A Barrier to Accessing Lifesaving Treatment for Opioid Use Disorder? Prior Authorization Insurance Requirements: A Barrier to Accessing Lifesaving Treatment for Opioid Use Disorder?
Pharmaceutical policy must facilitate, not hinder, timely and adequate access to medication and supporting care.
-
Read more: Eliminating Barriers to Opioid Use Disorder Treatment Eliminating Barriers to Opioid Use Disorder Treatment
We know how to prevent overdose deaths, and yet, the majority of individuals with opioid use disorder lack access to the standard of care treatment.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of March 2021.
-
Read more: Obstacles and Advances to Accessing Medication for Opioid Use Disorder Obstacles and Advances to Accessing Medication for Opioid Use Disorder
There are a number of barriers — both legal and cultural — that prevent patients from accessing the treatment they need for opioid use disorder.
